PerkinElmer

Immuno-oncology & Immunotherapy Research

Over the past decade immuno-oncology (I-O) has emerged as an exciting area of personalized medicine because of its tremendous potential to harness the body’s immune system to fight cancer. The basis for I-O is that the immune system can recognize and eliminate tumors through the process of immuno-surveillance. However, many tumors can evade or suppress the immune system, essentially ‘tricking’ the body into thinking those cells are normal.

Immunotherapy is used to fight off diseases such as cancer by stimulating or boosting the patients own immune system or giving man-made immune system proteins to attack cancer cells. Some types of cancers respond well to immunotherapy treatment alone while other cancers respond better when used in combination with other types of treatment such as chemotherapy.

Types of cancer immunotherapy include:

  • Monoclonal antibodies (mAb) are engineered proteins that target tumor-associated antigens which in turn evokes an immune response to kill cancer cells
  • Checkpoint inhibitor therapy targets immune ‘checkpoints’, key regulators of the immune system which cancer cells use to their advantage to protect themselves from immune system attacks. Cancer cells can often escape detection by interfering with these checkpoints on immune cells, notably T-cells. This type of therapy, usually antibody-based, essentially takes the ‘brakes’ off of the immune system and restores immune function by recognizing and destroying cancer cells. There are several checkpoint targets including PD-1 and CTLA-4 which are found on T-cells and PD-L1 found on cancer cells.
  • Cytokines such as interferon interferes with the way cancer cells grow and multiply, stimulates the immune system, and encourages cancer cells to produce chemicals that evoke an immune response
  • Vaccine therapy activates and stimulates the immune system to make antibodies to recognize and fight the disease
  • Adoptive cell transfer such as chimeric antigen receptor (CAR-T) cell therapy in which the patient’s T-cells are extracted, genetically modified, and transferred back into the patient with the aim that these altered cells can now recognize and attack cancer cells
 

PerkinElmer recognizes that the field of immuno-oncology is complex and researchers are faced with many challenges to better understand the relationship between the immune system, tumor biology and tumor microenvironment. We offer a wide range of tools to support and advance your immuno-oncology research to help you redefine and develop personalized, life-changing immunotherapies to treat cancer.

Featured Solutions

Immuno-oncology Reagents

Immuno-oncology (I-O) is a rapidly expanding area of personalized medicine. Researchers are exploring the complex relationship between tumor cells and the immun ...

Learn More

Microplate Readers

Performance, Versatility, and Reliability for Today’s Laboratory Needs As many of you know, microplate readers are instruments used to detect biological, chemic ...

Learn More

High Content Screening & Analysis

High-Content Analysis (HCA) or High-Content Screening (HCS) combines high-throughput automated imaging and analysis to extract quantitative multi-parametric dat ...

Learn More

In Vivo Imaging Instruments

Seamlessly monitor both functional and anatomical attributes of disease, decreasing both the time and cost of your experiments. Our best-in-class instruments fa ...

Learn More

Featured Products

IVIS Lumina S5 Imaging System

The IVIS® Lumina™ S5 high-throughput 2D optical imaging system combines high-sensitivity bioluminescence and fluorescence in a benchtop format. With an expanded ...

Learn More

IVIS Spectrum In Vivo Imaging System

The IVIS® Spectrum in vivo imaging system combines 2D optical and 3D optical tomography in one platform. The system uses leading optical technology for preclini ...

Learn More

Opera Phenix High-Content Screening System

The Opera Phenix HCS system has been replaced by the Opera Phenix Plus system. Please visit the Opera Phenix Plus webpage.

Learn More

PD-L1 (human) AlphaLISA Detection Kit, 100 assay points

The AlphaLISA® Human PD-L1 Detection Kit is designed for detection and quantitation of human Programmed death ligand 1 (PD-L1; CD274/B7-H1) in cell culture medi ...

Learn More

PD-L1 (human) LANCE Ultra TR-FRET Detection Kit, 500 Assay Points

The LANCE® Ultra Human PD-L1 Detection Kit is designed for detection and quantitation of human PD-L1 in buffered solution and cell culture media using a homogen ...

Learn More

VICTOR Nivo Multimode Microplate Reader

Now with Alpha Technology, the VICTOR® Nivo™ system packs all popular detection modes into the industry’s smallest multimode reader footprint. The perfect micro ...

Learn More

Explore Our Solutions

Genomics Solutions for Cancer Research

Advances in genomic technologies has improved our understanding of the biology of cancer. Genomic approaches to cancer research can be use to study its mechanis ...

Learn More

Biochemical Assay Solutions Cancer Research

Our understanding of tumor biology is constantly evolving as well as new treatment strategies. Although biochemical assays have been used for decades to detect ...

Learn More

Cell-Based Solutions Cancer Research

Cell-based assays are a proven and powerful tool for gaining a more complete understanding of cancer biology, providing more meaningful results in more physiolo ...

Learn More

Animal Imaging Solutions Cancer Research

Study cancer biology and assess therapeutic efficacy in vivo. Small animal imaging is becoming an increasingly important tool for studying cancer research by pr ...

Learn More